216 related articles for article (PubMed ID: 17977901)
1. Low-level neonatal thimerosal exposure: further evaluation of altered neurotoxic potential in SJL mice.
Berman RF; Pessah IN; Mouton PR; Mav D; Harry J
Toxicol Sci; 2008 Feb; 101(2):294-309. PubMed ID: 17977901
[TBL] [Abstract][Full Text] [Related]
2. Transcriptomic analyses of neurotoxic effects in mouse brain after intermittent neonatal administration of thimerosal.
Li X; Qu F; Xie W; Wang F; Liu H; Song S; Chen T; Zhang Y; Zhu S; Wang Y; Guo C; Tang TS
Toxicol Sci; 2014 Jun; 139(2):452-65. PubMed ID: 24675092
[TBL] [Abstract][Full Text] [Related]
3. Neurotoxic effects of postnatal thimerosal are mouse strain dependent.
Hornig M; Chian D; Lipkin WI
Mol Psychiatry; 2004 Sep; 9(9):833-45. PubMed ID: 15184908
[TBL] [Abstract][Full Text] [Related]
4. Mercury concentrations in brain and kidney following ethylmercury, methylmercury and Thimerosal administration to neonatal mice.
Harry GJ; Harris MW; Burka LT
Toxicol Lett; 2004 Dec; 154(3):183-9. PubMed ID: 15501610
[TBL] [Abstract][Full Text] [Related]
5. Identification and distribution of mercury species in rat tissues following administration of thimerosal or methylmercury.
Rodrigues JL; Serpeloni JM; Batista BL; Souza SS; Barbosa F
Arch Toxicol; 2010 Nov; 84(11):891-6. PubMed ID: 20386881
[TBL] [Abstract][Full Text] [Related]
6. Induction of metallothionein in mouse cerebellum and cerebrum with low-dose thimerosal injection.
Minami T; Miyata E; Sakamoto Y; Yamazaki H; Ichida S
Cell Biol Toxicol; 2010 Apr; 26(2):143-52. PubMed ID: 19357975
[TBL] [Abstract][Full Text] [Related]
7. Modeling neurodevelopment outcomes and ethylmercury exposure from thimerosal-containing vaccines.
Dórea JG; Marques RC
Toxicol Sci; 2008 Jun; 103(2):414-5; author reply 416. PubMed ID: 18364366
[No Abstract] [Full Text] [Related]
8. Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines.
Pichichero ME; Gentile A; Giglio N; Umido V; Clarkson T; Cernichiari E; Zareba G; Gotelli C; Gotelli M; Yan L; Treanor J
Pediatrics; 2008 Feb; 121(2):e208-14. PubMed ID: 18245396
[TBL] [Abstract][Full Text] [Related]
9. Persistent behavioral impairments and alterations of brain dopamine system after early postnatal administration of thimerosal in rats.
Olczak M; Duszczyk M; Mierzejewski P; Meyza K; Majewska MD
Behav Brain Res; 2011 Sep; 223(1):107-18. PubMed ID: 21549155
[TBL] [Abstract][Full Text] [Related]
10. Toxicokinetics of mercury after long-term repeated exposure to thimerosal-containing vaccine.
Barregard L; Rekić D; Horvat M; Elmberg L; Lundh T; Zachrisson O
Toxicol Sci; 2011 Apr; 120(2):499-506. PubMed ID: 21252391
[TBL] [Abstract][Full Text] [Related]
11. Thimerosal distribution and metabolism in neonatal mice: comparison with methyl mercury.
Zareba G; Cernichiari E; Hojo R; Nitt SM; Weiss B; Mumtaz MM; Jones DE; Clarkson TW
J Appl Toxicol; 2007; 27(5):511-8. PubMed ID: 17582588
[TBL] [Abstract][Full Text] [Related]
12. Thimerosal exposure in infants and developmental disorders: a retrospective cohort study in the United kingdom does not support a causal association.
Andrews N; Miller E; Grant A; Stowe J; Osborne V; Taylor B
Pediatrics; 2004 Sep; 114(3):584-91. PubMed ID: 15342825
[TBL] [Abstract][Full Text] [Related]
13. Comparison of organic and inorganic mercury distribution in suckling rat.
Orct T; Blanusa M; Lazarus M; Varnai VM; Kostial K
J Appl Toxicol; 2006; 26(6):536-9. PubMed ID: 17080402
[TBL] [Abstract][Full Text] [Related]
14. An assessment of downward trends in neurodevelopmental disorders in the United States following removal of Thimerosal from childhood vaccines.
Geier DA; Geier MR
Med Sci Monit; 2006 Jun; 12(6):CR231-9. PubMed ID: 16733480
[TBL] [Abstract][Full Text] [Related]
15. Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years.
Thompson WW; Price C; Goodson B; Shay DK; Benson P; Hinrichsen VL; Lewis E; Eriksen E; Ray P; Marcy SM; Dunn J; Jackson LA; Lieu TA; Black S; Stewart G; Weintraub ES; Davis RL; DeStefano F;
N Engl J Med; 2007 Sep; 357(13):1281-92. PubMed ID: 17898097
[TBL] [Abstract][Full Text] [Related]
16. Lasting neuropathological changes in rat brain after intermittent neonatal administration of thimerosal.
Olczak M; Duszczyk M; Mierzejewski P; Wierzba-Bobrowicz T; Majewska MD
Folia Neuropathol; 2010; 48(4):258-69. PubMed ID: 21225508
[TBL] [Abstract][Full Text] [Related]
17. Toxicity of ethylmercury (and Thimerosal): a comparison with methylmercury.
Dórea JG; Farina M; Rocha JB
J Appl Toxicol; 2013 Aug; 33(8):700-11. PubMed ID: 23401210
[TBL] [Abstract][Full Text] [Related]
18. The evidence for the safety of thiomersal in newborn and infant vaccines.
Clements CJ
Vaccine; 2004 May; 22(15-16):1854-61. PubMed ID: 15121295
[TBL] [Abstract][Full Text] [Related]
19. Neurotoxic character of thimerosal and the allometric extrapolation of adult clearance half-time to infants.
Magos L
J Appl Toxicol; 2003; 23(4):263-9. PubMed ID: 12884410
[TBL] [Abstract][Full Text] [Related]
20. Alteration of the spontaneous systemic autoimmune disease in (NZB x NZW)F1 mice by treatment with thimerosal (ethyl mercury).
Havarinasab S; Hultman P
Toxicol Appl Pharmacol; 2006 Jul; 214(1):43-54. PubMed ID: 16443248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
